Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dayong Zhai

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cancer Cell|October 7, 2008
A short Nur77-derived peptide converts Bcl-2 from a protector to a killerSiva Kumar Kolluri, Xiuwen Zhu, Xin Zhou, et al.
Molecular Cancer Therapeutics|April 18, 2009
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteinsJun Wei, Shinichi Kitada, Michele F Rega, et al.
Cancer Discovery|August 11, 2018
Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front MutationsAlexander Drilon, Sai-Hong Ignatius Ou, Byoung Chul Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Bcl-B expression in human epithelial and nonepithelial malignanciesMaryla Krajewska, Shinichi Kitada, Jane N Winter, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
Journal of Biomolecular Screening|May 30, 2014
Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family ProteinsChristian A Hassig, Fu-Yue Zeng, Paul Kung, et al.
Cell Stem Cell|January 22, 2013
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibitionDaniel J Goff, Angela Court Recart, Anil Sadarangani, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cancer Cell|October 7, 2008
A short Nur77-derived peptide converts Bcl-2 from a protector to a killerSiva Kumar Kolluri, Xiuwen Zhu, Xin Zhou, et al.
Molecular Cancer Therapeutics|April 18, 2009
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteinsJun Wei, Shinichi Kitada, Michele F Rega, et al.
Cancer Discovery|August 11, 2018
Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front MutationsAlexander Drilon, Sai-Hong Ignatius Ou, Byoung Chul Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Bcl-B expression in human epithelial and nonepithelial malignanciesMaryla Krajewska, Shinichi Kitada, Jane N Winter, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
Journal of Biomolecular Screening|May 30, 2014
Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family ProteinsChristian A Hassig, Fu-Yue Zeng, Paul Kung, et al.
Cell Stem Cell|January 22, 2013
A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibitionDaniel J Goff, Angela Court Recart, Anil Sadarangani, et al.
Pageof 5